Answers are grounded in this paper and cite their sources.
Background: Cryptosporidium is a life-threatening intestinal pathogen in immunocompromised patients.Currently, there is no entirely successful drug against cryptosporidiosis. Several reports utilizingnanotechnology combined with herbal medicine were published to evaluate its efficacy in treatment ofintestinal pathogens.Objectives: To evaluate the anti-cryptosporidial efficacy of Commiphora molmol extract and its conjugationwith chitosan nanofibers (CsNFs) for treatment of cryptosporidiosis in mice.Material and Methods: Sixty-five male albino mice were infected orally with 104 Cryptosporidium oocysts.They were grouped and treated with nanazoxid (NTZ) (100 mg/kg), C. molmol extract (500 mg/kg), andC. molmol loaded chitosan nanofibers (Cm-CsNFs) at 25, 50, and 100 mg/kg. The scarification of micewas done after 5 and 10 days of treatments. Assessment of the treatments' efficacy was achieved usingparasitological parameters: oocysts and trophozoites counts, and histopathological examination.Results: C. molmol extract and Cm-CsNFs (100 mg/kg) significantly reduced the mean number of intestinaloocysts. All the treatment regimens significantly (P<0.05) diminished the mean number of trophozoitesrelative to the infected non-treated group. Apparent pathological alterations in intestinal tissues wereconsistent with cryptosporidiosis. Cryptosporidium-induced pathological alterations were improvedremarkably in Cm-CsNFs (100 mg/kg) group.Conclusion: Our study highlights the efficacy of C. molmol as an extract or conjugated with CsNFs indeclining cryptosporidiosis and attenuating Cryptosporidium-induced intestinal injury.
No takes yet. Share an insight, caveat, or question.
Fahmy et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: